Cell and Tissue Culture Incubators Market Size

  • Report ID: 4050
  • Published Date: Nov 21, 2025
  • Report Format: PDF, PPT

Cell and Tissue Culture Incubators Market Outlook:

Cell and Tissue Culture Incubators Market size was valued at USD 3.79 billion in 2025 and is set to exceed USD 7.25 billion by 2035, registering over 6.7% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of cell and tissue culture incubators is evaluated at USD 4.02 billion.

The growth of the market can be attributed to the increasing number of chronic diseases. The desire for novel medicines and treatments is being driven by the rising prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders. For instance, several of these therapies are based on cell and gene therapies, which call for the utilization of sophisticated cell culture methods and premium incubation equipment. By 2030, there will be over 40 million more Americans who suffer from chronic illnesses.

In addition to these, factors that are believed to fuel the market growth of cell and tissue culture incubators include the rise in technological advancements. Technology advancements have resulted in the creation of more advanced cell and tissue culture incubators. For instance, some incubators now come equipped with enhanced imaging capabilities, and remote monitoring, which are increasing the demand in industrial and research environments.


Cell and Tissue Culture Incubators Market size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of cell and tissue culture incubators is evaluated at USD 4.02 billion.

The global cell and tissue culture incubators market size was worth around USD 3.79 billion in 2025 and is set to register a CAGR of more than 6.7%, exceeding USD 7.25 billion revenue by 2035.

By 2035, North America is projected to secure a 35% share in the cell and tissue culture incubators market, fueled by escalating cancer prevalence and the resulting surge in research demand.

Key players in the market include Thermo Fisher Scientific Inc., Memmert Gmbh+ Co. KG, BINDER GmbH, PHC Holdings Corporation, Sheldon Manufacturing INC, Bionics Scientific Technologies (P) Ltd, BioSpherix, Ltd., Adolf Kühner AG, Acmas Technologies Inc., Cole-Parmer Instrument Company, LLC.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos